Literature DB >> 12929881

Underlying causes of recurrent pneumonia in Turkish children in a university hospital.

Ergin Ciftçi1, Meltem Güneş, Yavuz Köksal, Erdal Ince, Ulker Doğru.   

Abstract

The aim of this study was to determine the relative frequency of underlying illnesses for recurrent pneumonia in children. Children who had two or more episodes of pneumonia per year, or three or more episodes in a lifetime were investigated retrospectively at Ankara University Medical School, Department of Pediatric Infectious Diseases, between January 1997 and October 2002. Out of 788 children hospitalized for pneumonia, 71 (9 per cent) met the criteria for recurrent pneumonia. An underlying illness was demonstrated in 60 patients (85 per cent). In this group, the underlying illness was diagnosed prior to pneumonia in 11 patients (18.3 per cent), during the first episode in 12 patients (20 per cent), and during recurrence in 37 patients (61.7 per cent). Underlying diseases were bronchial asthma (32 per cent), gastroesophageal reflux (15 per cent), immune disorders (10 per cent), congenital heart defects (9 per cent), anomalies of the chest and lung (6 per cent), bronchopulmonary dysplasia (4 per cent), cystic fibrosis (3 per cent), tuberculosis (3 per cent), and aspiration syndrome (3 per cent). No predisposing illness could be demonstrated in 11 patients (15 per cent). In conclusion, approximately one-tenth of hospitalized children with pneumonia in our hospital had recurrent pneumonia. Most of these children had an underlying illness, which was demonstrated by intensive investigation. Bronchial asthma in children aged more than 2 years and gastroesophageal reflux in children aged less than 1 year were the most common underlying illnesses for recurrent pneumonia.

Entities:  

Mesh:

Year:  2003        PMID: 12929881     DOI: 10.1093/tropej/49.4.212

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  8 in total

Review 1.  Recurrent Pneumonia in Children: A Reasoned Diagnostic Approach and a Single Centre Experience.

Authors:  Silvia Montella; Adele Corcione; Francesca Santamaria
Journal:  Int J Mol Sci       Date:  2017-01-29       Impact factor: 5.923

2.  Childhood recurrent pneumonia caused by endobronchial sutures: A case report.

Authors:  Yiheng Zan; Hanmin Liu; Lin Zhong; Li Qiu; Qingfen Tao; Lina Chen
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

3.  Assessment of the prevalence of congenital heart disease in children with pneumonia in tertiary care hospital: A cross-sectional study.

Authors:  Neeraj Kumar Jat; D K Bhagwani; Namita Bhutani; Urvashi Sharma; Ram Sharma; Raju Gupta
Journal:  Ann Med Surg (Lond)       Date:  2021-11-23

4.  Risk factors for recurrent respiratory tract infection in preschool-aged children.

Authors:  Bo Zhou; Wenquan Niu; Fangyu Liu; Yuan Yuan; Kundi Wang; Jing Zhang; Yunfeng Wang; Zhixin Zhang
Journal:  Pediatr Res       Date:  2020-11-10       Impact factor: 3.756

5.  Recurrent/Persistent Pneumonia among Children in Upper Egypt.

Authors:  Khaled Saad; Sherif A Mohamed; Kotb A Metwalley
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-04-18       Impact factor: 2.576

6.  Clinical profile of recurrent community-acquired pneumonia in children.

Authors:  Francesca Patria; Benedetta Longhi; Claudia Tagliabue; Rossana Tenconi; Patrizia Ballista; Giuseppe Ricciardi; Carlotta Galeone; Nicola Principi; Susanna Esposito
Journal:  BMC Pulm Med       Date:  2013-10-10       Impact factor: 3.317

7.  Severe recurrent pneumonia in children: Underlying causes and clinical profile in Vietnam.

Authors:  Kim Lam Hoang; Anh Tuan Ta; Van Thang Pham
Journal:  Ann Med Surg (Lond)       Date:  2021-06-09

8.  Prevalence of monogenic disease in paediatric patients with a predominant respiratory phenotype.

Authors:  Dan Dai; Mei Mei; Liyuan Hu; Yun Cao; Xiaochuan Wang; Libo Wang; Yulan Lu; Lin Yang; Xinran Dong; Huijun Wang; Bingbing Wu; Liling Qian
Journal:  Arch Dis Child       Date:  2021-06-16       Impact factor: 3.791

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.